UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 410

Sortiert nach

Natural killer cells in antiviral immunity

Nature reviews. Immunology, 2022-02, Vol.22 (2), p.112

2022

Link zum Volltext

Verfügbarkeit prüfen

SARS‐CoV‐2 antibody titers at the time of hospital admission and risk for mortality

Journal of internal medicine, 2023-06, Vol.293 (6), p.664-665

Ljunggren, Hans‐Gustaf

2023

Link zum Volltext

Verfügbarkeit prüfen

Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?

European journal of immunology, 2023-11, Vol.53 (11), p.e2350465-e2350465

2023

Link zum Volltext

Verfügbarkeit prüfen

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

Nature medicine, 2022-03, Vol.28 (3), p.472-476

2022

Link zum Volltext

Verfügbarkeit prüfen

Seminal immunologic discoveries with direct clinical implications: The 2018 Nobel Prize in Physiology or Medicine honours discoveries in cancer immunotherapy

Scandinavian journal of immunology, 2018-12, Vol.88 (6), p.e12731-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Paths taken towards NK cell–mediated immunotherapy of human cancer—a personal reflection

Scandinavian journal of immunology, 2021-01, Vol.93 (1), p.e12993-n/a

Ljunggren, Hans‐Gustaf

2021

Link zum Volltext

Verfügbarkeit prüfen

Nonreversible MAIT cell‐dysfunction in chronic hepatitis C virus infection despite successful interferon‐free therapy

European journal of immunology, 2016-09, Vol.46 (9), p.2204-2210

2016

Link zum Volltext

Verfügbarkeit prüfen

Prospects for the use of NK cells in immunotherapy of human cancer

Nature Reviews: Immunology, 2007-05, Vol.7 (5), p.329-339

2007

Link zum Volltext

Verfügbarkeit prüfen

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

Blood, 2010-03, Vol.115 (11), p.2167-2176

2010

Link zum Volltext

Verfügbarkeit prüfen

Organ-specific features of natural killer cells

Nature reviews. Immunology, 2011-10, Vol.11 (10), p.658

2011

Link zum Volltext

Verfügbarkeit prüfen

Activation, coactivation, and costimulation of resting human natural killer cells

Immunological reviews, 2006-12, Vol.214 (1), p.73-91

2006

Link zum Volltext

Verfügbarkeit prüfen

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Clinical cancer research, 2018-04, Vol.24 (8), p.1834-1844

2018

Link zum Volltext

Verfügbarkeit prüfen

Covid‐19, SSI 50 years and Nobel: Three immunological reasons to remember 2020

Scandinavian journal of immunology, 2020-12, Vol.92 (6), p.e12997-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

Blood, 2013-04, Vol.121 (14), p.2678-2688

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome of COVID‐19 in multiple myeloma patients in relation to treatment

European journal of haematology, 2020-12, Vol.105 (6), p.751-754

2020

Link zum Volltext

Verfügbarkeit prüfen

Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells

Nature communications, 2019-08, Vol.10 (1), p.3841-12, Article 3841

2019

Link zum Volltext

Verfügbarkeit prüfen

Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells

The Journal of immunology (1950), 2015-03, Vol.194 (6), p.2467-2471

2015

Link zum Volltext

Verfügbarkeit prüfen

Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors

Blood, 2009-09, Vol.114 (13), p.2657-2666

2009

Link zum Volltext

Verfügbarkeit prüfen

Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients

The Journal of immunology (1950), 2020-11, Vol.205 (9), p.2437-2446

2020

Link zum Volltext

Verfügbarkeit prüfen

Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

Nature communications, 2018-06, Vol.9 (1), p.2275-12, Article 2275

2018

Link zum Volltext

Verfügbarkeit prüfen

Hantavirus inhibits apoptosis by preventing mitochondrial membrane potential loss through up-regulation of the pro-survival factor BCL-2

PLoS pathogens, 2020-02, Vol.16 (2), p.e1008297-e1008297

2020

Link zum Volltext

Verfügbarkeit prüfen

Nobel 2022: An extraordinary achievement relevant to immunity

Scandinavian journal of immunology, 2022-12, Vol.96 (6), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

Blood, 2010-02, Vol.115 (6), p.1166-1174

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 410

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(394)
Mit Volltextzugriff
(384)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(283)
Medicin Och Hälsovetenskap
(277)
Life Sciences & Biomedicine
(266)
Immunology
(198)
Animals
(160)
Humans
(155)
Mice
(136)
Killer Cells, Natural - Immunology
(121)
Mice, Inbred C57bl
(68)
Biological And Medical Sciences
(63)
Killer Cells, Natural - Metabolism
(50)
Female
(49)
Male
(46)
Immunology And Allergy
(39)
Medical Sciences
(39)
Cells, Cultured
(37)
Cell Biology
(36)
Flow Cytometry
(35)
Mice, Knockout
(34)
Natural Killer Cells
(33)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Natural killer cells in antiviral immunity

SARS‐CoV‐2 antibody titers at the time of hospital admission and risk for mortality

Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

Seminal immunologic discoveries with direct clinical implications: The 2018 Nobel Prize in Physiology or Medicine honours discoveries in cancer immunotherapy

Paths taken towards NK cell–mediated immunotherapy of human cancer—a personal reflection

Nonreversible MAIT cell‐dysfunction in chronic hepatitis C virus infection despite successful interferon‐free therapy

Prospects for the use of NK cells in immunotherapy of human cancer

Regulation of human NK-cell cytokine and chemokine production by target cell recognition

Organ-specific features of natural killer cells

Activation, coactivation, and costimulation of resting human natural killer cells

Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML

Covid‐19, SSI 50 years and Nobel: Three immunological reasons to remember 2020

NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs

Outcome of COVID‐19 in multiple myeloma patients in relation to treatment

Unique transcriptional and protein-expression signature in human lung tissue-resident NK cells

Natural killer cell immunotypes related to COVID-19 disease severity

Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells

Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors

Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients

Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial

Hantavirus inhibits apoptosis by preventing mitochondrial membrane potential loss through up-regulation of the pro-survival factor BCL-2

Nobel 2022: An extraordinary achievement relevant to immunity

Education of human natural killer cells by activating killer cell immunoglobulin-like receptors

Suchergebnisse filtern